Company / Cash per Share
ANI Pharmaceuticals, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$13.53
FY2025
5-year range
$2.97 / $13.53
FY2021-FY2025
Trend
+51.9%
vs FY2024
Sector context
#14 of 205
Health Care
What the data says
Among 205 Health Care companies, ANI Pharmaceuticals, Inc. is in the top 7% for cash per share. Cash per Share has fluctuated over the past 10 years, ranging from $0.66 in FY2020 to $13.53 in FY2025.
Based on SEC 10-K filings.
13.53 in FY2025 with a 5-year CAGR of +83.1%. Top quartile in the Health Care sector.
Improved from $12.15 to $13.53 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +65.8%
- 5-Year CAGR
- +83.1%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 205This company $13.53 Sector average $72.93
▼
-81.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 51.9% year-over-year.
- Ranks #14 out of 205 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.53 | +51.9% |
| FY2024 | $8.91 | -26.7% |
| FY2023 | $12.15 | +309.8% |
| FY2022 | $2.97 | -62.8% |
| FY2021 | $7.96 | +1111.4% |
| FY2020 | $0.66 | -87.8% |
| FY2019 | $5.40 | +47.8% |
| FY2018 | $3.65 | +35.6% |
| FY2017 | $2.69 | +14.0% |
| FY2016 | $2.36 | -99.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026